drugset / Trial / NCT01395329
Nebivolol and the Endothelin (ET)-1 System
RandomizedParallel-groupTriple-blindOther
Summary
The investigators hypothesize that nebivolol will reduce ET-1-mediated vasoconstrictor tone in adult humans with elevated blood pressure to a greater extent than either metoprolol or placebo.
Timeline
- Start
- 2011-05
- Primary completion
- 2016-11
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metoprolol | Other / unclassified | 100 mg | Oral |
| Comparator | Nebivolol | Other / unclassified | 5 mg | Oral |